Abstract:Background Radiotherapy is one of the most important therapeutic strategies for treating cancer. For decades, studies concerning the outcomes of radiotherapy mainly focused on the biological effects of radiation on tumor cells. Recently, we have increasingly recognized that the complex cellular interactions within the tumor microenvironment (TME) are closely related to treatment outcomes. Main content As a critical component of the TME, fibroblasts participate in all stages of cancer progression. Fibroblasts are able to tolerate harsh extracellular environments, which are usually fatal to all other cells. They play pivotal roles in determining the treatment response to chemoradiotherapy. Radiotherapy activates the TME networks by inducing cycling hypoxia, modulating immune reaction, and promoting vascular regeneration, inflammation and fibrosis. While a number of studies claim that radiotherapy affects fibroblasts negatively through growth arrest and cell senescence, others argue that exposure to radiation can induce an activated phenotype in fibroblasts. These cells take an active part in constructing the tumor microenvironment by secreting cytokines and degradative enzymes. Current strategies that aim to inhibit activated fibroblasts mainly focus on four aspects: elimination, normalization, paracrine signaling blockade and extracellular matrix inhibition. This review will describe the direct cellular effects of radiotherapy on fibroblasts and the underlying genetic changes. We will also discuss the impact of fibroblasts on cancer cells during radiotherapy and the potential value of targeting fibroblasts to enhance the clinical outcome of radiotherapy. Conclusion This review provides good preliminary data to elucidate the biological roles of CAFs in radiotherapy and the clinical value of targeting CAFs as a supplementary treatment to conventional radiotherapy. Further studies to validate this strategy in more physiological models may be required before clinical trial.

Editorial: Crosstalk Between Cancer-Associated Fibroblasts and Tumor Cells in the Tumor Microenvironment: an Emerging Target of Anti-Cancer Immunotherapy

Editorial: The cross-talk between cancer cells and immune cells in the tumor microenvironment

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment

Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

Editorial: Anti-cancer effects of botanical drugs targeting the tumor microenvironment

Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

[Progress on Cancer Associated Fibroblasts in Tumor Immunoregulation].

Cancer Associated Fibroblasts: an Essential Role in the Tumor Microenvironment

Crosstalk between cancer‐associated fibroblasts and immune cells in cancer

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy

Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment

The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment

CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies.

Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments

Turning foes to friends: targeting cancer-associated fibroblasts